Physician profile
Asima Rahman
NPI 1043537939
$3,266.73
in general payments reported to CMS, 2019-2025
19 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.19 · 2020: $123 · 2021: $317 · 2022: $503 · 2023: $700 · 2024: $562 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,286.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $635.36 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $489.99 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $413.04 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $351.64 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.15 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Dexcom, INC. | $267.54 | 2023-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $217.14 | 2023-2025 | |
| Abbott Laboratories | $155.13 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $119.88 | 2024-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $111.45 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $61.44 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $48.54 | 2021 | |
| Globus Medical, INC. | $27.58 | 2025 | Senza |
| Phadia US INC. | $23.29 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.27 | 2025 | Zoryve |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.70 | 2020 | |
| Corcept Therapeutics | $13.21 | 2022 | |
| Pfizer INC. | $12.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asima Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.